Eric S. Zhou

Eric S. Zhou

Auto-generated profile, based on publicly available information

Eric S. Zhou

Division of Sleep Medicine, Harvard Medical School , Boston, MA

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2007 in Psychological Bulletin
Verified
Journal Article
Closed access
GMGregory E. Miller
Gregory E. Miller
ECEdith Chen
Edith Chen
EZEric S. Zhou
Eric S. Zhou
The notion that chronic stress fosters disease by activating the hypothalamic-pituitary-adrenocortical (HPA) axis is featured prominently in many theories. The research linking chronic stress and HPA function is contradictory, however, with some studies reporting increased activation, and others reporting the opposite. This meta-analysis showed that much of the variability is attributable to stressor and person features. Timing is an especially critical element, as hormonal activity is elevated at stressor onset but reduces as time passes. Stressors that threaten physical integrity, involve trauma, and are uncontrollable elicit a high, flat diurnal profile of cortisol secretion. Finally, HPA activity is shaped by a person's response to the situation; it increases with subjective distress but is lower in persons with posttraumatic stress disorder.

20 April 2022 in JAMA Psychiatry
Verified
Journal Article
Open access
PDF file
EZEric S. Zhou
Eric S. Zhou
LRLee M. Ritterband
Lee M. Ritterband
TBTraci N. Bethea
Traci N. Bethea
YRYvonne P. Robles
Yvonne P. Robles
THTimothy C. Heeren
Timothy C. Heeren
LRLynn Rosenberg
Lynn Rosenberg
Insomnia is associated more frequently with psychiatric disorders than any other medical illness,1 contributes to an increased risk of cardiovascular disease,2 obesity,3 and home, motor vehicle, and workplace unintentional injuries,4 and results in substantially poorer quality of life.5 Women are up to 40% more likely to have insomnia disorder during their lifetime than men and are more likely to experience multiple insomnia symptoms.6,7 In one national survey, 67% of women reported at least a few nights of sleep difficulty in the past month.8

1 August 2013 in The Journal of Sexual Medicine
Verified
Journal Article
Closed access
PDF file
SBSharon L. Bober
Sharon L. Bober
EZEric S. Zhou
Eric S. Zhou
BCBing Chen
Bing Chen
PMPeter E. Manley
Peter E. Manley
LKLisa B. Kenney
Lisa B. Kenney
CRChristopher J. Recklitis
Christopher J. Recklitis

5 August 2016 in Journal of Cancer Survivorship
Verified
Journal Article
Closed access
PDF file
EZEric S. Zhou
Eric S. Zhou
APAnn H. Partridge
Ann H. Partridge
KSKaren L. Syrjala
Karen L. Syrjala
AMAlexis L. Michaud
Alexis L. Michaud
CRChristopher J. Recklitis
Christopher J. Recklitis

30 March 2017 in British Journal of Cancer
Verified
Journal Article
Open access
Claudia Trudel-FitzgeraldClaudia Trudel-Fitzgerald
Claudia Trudel-Fitzgerald
EZEric S Zhou
Eric S Zhou
EPElizabeth M Poole
Elizabeth M Poole
XZXuehong Zhang
Xuehong Zhang
KMKarin B Michels
Karin B Michels
Eva SchernhammerEva Schernhammer
Eva Schernhammer
Breast cancer is a leading cause of cancer death in women. Sleep has been linked with mortality among cancer-free population; however, its association with survival among women with breast cancer is understudied. Breast cancer patients (N=3682) reported their average sleep duration post diagnosis. Subsamples also provided their pre-diagnosis sleep duration (n=1949) and post-diagnosis sleep difficulties (n=1353). Multivariate Cox models estimated hazard ratios (HR) and confidence intervals (CI) of all-cause, breast cancer, and non-breast cancer mortality. At diagnosis, the mean age was 64.9 years and 91.7% were stage I or II. Women sleeping ⩾9 h per night post diagnosis had a strong higher risk of all-cause (multivariate HRs: MV-HR=1.37, CI=1.10-1.71), breast cancer (MV-HR=1.46, CI=1.02-2.07), and non-breast cancer mortality (MV-HR=1.34, CI=1.01-1.79), compared to women sleeping 8 h per night. Increased sleep duration post diagnosis (vs unchanged) and regular sleep difficulties (vs rare/none) were associated with a strong elevated risk of all-cause mortality (MV-HRincreased duration=1.35, CI=1.04-1.74; MV-HRregular difficulties=1.49, CI=1.02-2.19) and a moderate greater risk of breast cancer and non-breast cancer mortality. Various facets of sleep were associated with higher all-cause mortality risk. If replicated, these findings support evaluation of breast cancer patients' sleep duration and difficulties to identify those at risk for poorer outcomes.

24 June 2011 in Psycho-Oncology
Verified
Journal Article
Closed access
PDF file
YKYoungmee Kim
Youngmee Kim
CCCharles S. Carver
Charles S. Carver
RSRachel L. Spillers
Rachel L. Spillers
CCCorinne Crammer
Corinne Crammer
EZEric S. Zhou
Eric S. Zhou